Who has invested in OncoResponse?

ARE, Rice University, Takeda Pharmaceuticals, Magnetar Group, Yonjin Venture, Bering Capital are named among the investors backing OncoResponse.

OncoResponse Funding: $150M Raised, Series D (2025)

OncoResponse funding overview

OncoResponse is based in Seattle, WA. OncoResponse has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in April 2025. The round record for OncoResponse runs through 2025; nothing later has been disclosed. Investors on record include ARE, Rice University, Takeda Pharmaceuticals, Magnetar Group, Yonjin Venture, Bering Capital and 7 others. 13 distinct backers are named across the disclosed rounds.

OncoResponse at a glance

Total raised: $150M
Latest round: Series D
Latest round date: April 2025
Headquarters: Seattle, WA
Notable investors: ARE, Rice University, Takeda Pharmaceuticals, Magnetar Group, Yonjin Venture, Bering Capital, RiverVest Venture Partners, Qatar Investment Authority

Frequently asked about OncoResponse funding

How much has OncoResponse raised?: OncoResponse has raised $150M in total disclosed funding across the rounds on record.
Who has invested in OncoResponse?: ARE, Rice University, Takeda Pharmaceuticals, Magnetar Group, Yonjin Venture, Bering Capital are named among the investors backing OncoResponse.
What was the latest OncoResponse funding round?: The most recent disclosed round is a Series D, announced in April 2025.
Where is OncoResponse based?: OncoResponse is based in Seattle, WA.
When did OncoResponse last raise?: The last disclosed OncoResponse round closed in April 2025 at Series D.

Round data for OncoResponse is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seattle and backer lists below.

OncoResponse Funding: $150M Raised, Series D (2025)

OncoResponse funding overview

OncoResponse at a glance

Frequently asked about OncoResponse funding

Companies related to OncoResponse (18)

Browse related funding lists (5)